Tackling liver cancer with interferon.
Schluger
L K
LK
Liver Transplantation Program, Mount Sinai Medical Center, New York, NY, USA.
Bodenheimer
H
H
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000998:Antiviral Agents / Q000627:therapeutic use*; D006528:Carcinoma, Hepatocellular / Q000628:therapy* / Q000821:virology; D006526:Hepatitis C / Q000150:complications; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D008103:Liver Cirrhosis / Q000821:virology; D008113:Liver Neoplasms / Q000628:therapy* / Q000821:virology; D011994:Recombinant Proteins; D012307:Risk Factors
D000970:Antineoplastic Agents; D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins